Total raised
$33.1M
Last: Series A 2026-02
Stage
Series A
Founded
2019
Headcount
18
HQ
Ramat HaSharon
Sector
Health Tech & Life Sciences
About
Starget Pharma is focused on creating products for the diagnosis and targeted treatment of cancer through the use of targeted radiotherapy. The company develops molecules that serve as a vector for selectively transferring imaging materials and treatments directly to tumor tissue.
Funding history · 3 rounds · $33.1M total
2026-02
Series A
$18.0M
2024-10
Seed
$5.1M
2019-12
Undisclosed
$10.0M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryTest Diagnostics & Screening
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Tags
cancer-therapypeptidespharmaceuticalsdiagnosticsbiotechnology